Search results
ACOG joins ASCCP and SGO in endorsing the USPSTF recommendations for cervical cancer screening in average-risk individuals aged 30–65 years. The guidelines include primary hrHPV testing, cytology alone, and co-testing as options, and recommend screening initiation at age 21 years.
Learn about the different types of cervical cancer screening tests, how often you need them, and who may need more frequent or less frequent screening. This infographic from the American College of Obstetricians and Gynecologists (ACOG) provides guidelines and exceptions based on age, history, and immune status.
ACOG supports the updated ASCCP guidelines for abnormal cervical cancer screening results, which follow a risk-based approach and consider patient history. The guidelines provide recommendations for colposcopy, treatment, surveillance, and HPV testing based on current and past test results.
15 sty 2021 · Current Cervical Cancer Screening and Surveillance Recommendations: US Preventive Services Task Force (USPSTF, 2018), American College of Obstetricians and Gynecologists (ACOG, 2016), American Cancer Society (ACS, 2020) and ASCCP (2019)
This article is a review of the current screening recommendations and potential future recommendations. Keywords: cervical cancer screening. Go to: 1. Introduction. Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases annually and approximately 350,000 cancer-related deaths per year [1].
This systematic review to support the 2018 US Preventive Services Task Force Recommendation Statement on screening for cervical cancer summarizes published evidence on the benefits and harms of using high-risk human papillomavirus (hrHPV) testing alone, hrHPV testing with cytology, or cytology alone for cervical cancer screening.
21 lip 2023 · The optimal screening strategy for cervical cancer must weigh the benefits of cancer detection against the harms of overtreatment; however, the ideal age of screening onset and frequency remain uncertain.
